# p53

> p53 is a VC fund in Stavanger backing Biotechnology, Medical and Life Science. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Stavanger, Norway
- Total investments: 2
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/p53/
- Website: https://p53.no/

p53 is a VC fund in Stavanger focused on Biotechnology and Medical. p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $30M–$81M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Life Science | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Norway | 1 | 50% |
| Denmark | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Calluna Pharma | Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases. | $81.4M | Series A | Jan 23, 2024 |  |
| Teitur Trophics | Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark. | $30M | Series A | Mar 14, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 3 deals together
- [Sarsia](https://shizune.co/investors/profile/sarsia) — VC Fund, 2 deals together
- [Industrifonden](https://shizune.co/investors/profile/industrifonden) — VC Fund, 1 deal together
- [Innovestor](https://shizune.co/investors/profile/innovestor) — VC Fund, 1 deal together
- [Investinor](https://shizune.co/investors/profile/investinor) — VC Fund, 1 deal together
- [Sound Bioventures](https://shizune.co/investors/profile/sound-bioventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund
- [PSV](https://shizune.co/investors/profile/preseed-innovation) — VC Fund
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Denmark](https://shizune.co/investors/medical-vc-funds-denmark)
- [Biotechnology Investors in Denmark](https://shizune.co/investors/biotechnology-investors-denmark)
- [Biotechnology VC Funds in Denmark](https://shizune.co/investors/biotechnology-vc-funds-denmark)
- [Health Care VC Funds in Denmark](https://shizune.co/investors/health-care-vc-funds-denmark)
- [Biotech VC Funds in Denmark](https://shizune.co/investors/biotech-vc-funds-denmark)
- [Life Science Investors in Denmark](https://shizune.co/investors/life-science-investors-denmark)

## FAQ

### What does p53 invest in?

p53 invests primarily in Biotechnology, Medical and Life Science startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is p53's check size?

p53 typically joins rounds of $30M–$81M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds p53 participates in.

### When did p53 last invest?

The most recent investment recorded for p53 closed in Jan 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co